Sitemap
Pages
Sitemap
News
- 30 Technology expands its clinical team
- 30 Technology receives regulatory approval for TASK tuberculosis Study in South Africa
- 30 Technology Expands Its Scientific Team And Opens New Innovation Hub At Scale Space, Imperial College London
- 30 Technology enters into a strategic Licencing Agreement to develop new treatments for multi-drug resistant tuberculosis
- 30 Technology launches a critical clinical trial of RESP301 in cystic fibrosis patients with serious lung infections
- Thirty Respiratory receives approval for multicentre post-exposure clinical trial of RESP301 to prevent transmission of COVID-19 in the community
- 30 Technology announces first patients enrolled in UK clinical trial (NOCoV2) for the treatment of COVID-19
Press Releases